ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646847 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646847; 2) Community: the network communities that were significantly associated with the response to NSC 646847; 3) Molecule: the relationships between components within communities and NSC 646847; 4) MDR: the compounds that were significantly associated with the NSC 646847.

NSC Compound Enrichment Correlation
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00265144454581183 0.26730016
NSC 678343 Null 0.00265144454581183 0.31631709
NSC 687522 Null 0.00265144454581183 0.11641561
NSC 701383 Null 0.00265144454581183 0.44108723
NSC 719715 Null 0.00265144454581183 0.39092723
NSC 720299 Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane 0.00265144454581183 0.33571976
NSC 721049 7Z-Plakortide H 0.00265144454581183 0.27127893
NSC 740 Methotrexate 0.00265144454581183 0.43009463
NSC 744063 Null 0.00265144454581183 0.22770681
NSC 87868 2-Phenylethyl isothiocyanate 0.00265144454581183 0.26189251
Total:118  Current:15    [First] [Prev] [Next] [Last]